1. Home
  2. AIHS vs EDSA Comparison

AIHS vs EDSA Comparison

Compare AIHS & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIHS

Senmiao Technology Limited

N/A

Current Price

$1.75

Market Cap

7.3M

Sector

Finance

ML Signal

N/A

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

HOLD

Current Price

$6.57

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIHS
EDSA
Founded
2014
2015
Country
China
Canada
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
7.5M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
AIHS
EDSA
Price
$1.75
$6.57
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
23.0K
7.4M
Earning Date
02-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
14.63
N/A
EPS
N/A
N/A
Revenue
$3,389,072.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.72
52 Week High
$8.26
$9.37

Technical Indicators

Market Signals
Indicator
AIHS
EDSA
Relative Strength Index (RSI) 72.72 59.46
Support Level $1.84 $1.69
Resistance Level $3.07 $8.74
Average True Range (ATR) 0.17 1.48
MACD 0.02 -0.03
Stochastic Oscillator 67.55 49.31

Price Performance

Historical Comparison
AIHS
EDSA

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: